Zhengye Biotechnology Holding Limited Ordinary Shares Capital Reinvestment Ratio
Zhengye Biotechnology Holding Limited Ordinary Shares capital reinvestment ratio. Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Capital Reinvestment Ratio of 0.68x as of December 2025, meaning it reinvests 1% of its operating cash flow ($41.05 Million) in capital expenditures ($27.77 Million). Check Zhengye Biotechnology Holding Limited Or investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Capital reinvestment ratio of Zhengye Biotechnology Holding Limited Ordinary Shares from 2021 to 2025. This chart tracks Zhengye Biotechnology Holding Limited Ordinary Shares's Capital Reinvestment Ratio across 5 annual periods. Also explore how fast is Zhengye Biotechnology Holding Limited Or growing its equity to track the company's year-over-year net asset growth rate.
Zhengye Biotechnology Holding Limited Ordinary Shares Capital Reinvestment Ratio by Year (2021–2025)
Zhengye Biotechnology Holding Limited Ordinary Shares capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see how efficiently does Zhengye Biotechnology Holding Limited Or generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | $41.05 Million | $27.77 Million | ▲ +0.0% |
| 2024 | 0.68x | $41.05 Million | $27.77 Million | ▲ +181.1% |
| 2023 | 0.24x | $48.18 Million | $11.60 Million | ▼ -84.7% |
| 2022 | 1.58x | $17.34 Million | $27.33 Million | ▲ +89.9% |
| 2021 | 0.83x | $31.81 Million | $26.40 Million | — |